New Study Reveals How Cancer Reprograms Immune Cells to Fuel Growth
Learn how a new study reveals cancer's strategy to reprogram immune cells into tumor allies, offering hope for improving immunotherapy response rates in patients.
This discovery matters because it explains why 80% of immunotherapy patients fail to respond, pointing to a mechanism that could be targeted to improve treatment outcomes. By revealing how cancer hijacks immune cells, researchers can develop new therapies to block this reprogramming, potentially turning non-responders into responders and saving countless lives.
